- Home
- Publications
- Publication Search
- Publication Details
Title
The estrogen pathway as a modulator of response to immunotherapy
Authors
Keywords
-
Journal
Immunotherapy
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2019-07-30
DOI
10.2217/imt-2019-0024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers
- (2019) Christopher J. D. Wallis et al. JAMA Oncology
- Predictors for clinical benefit of immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis
- (2019) Hazem El-Osta et al. Immunotherapy
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
- (2019) Gaurav Singal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis
- (2019) Fabio Conforti et al. JNCI-Journal of the National Cancer Institute
- Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
- (2018) E E Vokes et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Role of the Estrogen Pathway in the Tumor Microenvironment
- (2018) Natalie Rothenberger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer
- (2018) Edward B. Garon et al. LUNG CANCER
- Higher Lung Cancer Incidence in Young Women Than Young Men in the United States
- (2018) Ahmedin Jemal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of estrogen in non-small cell lung cancer and its clinical implications
- (2018) Vianey Rodriguez-Lara et al. Journal of Thoracic Disease
- Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
- (2018) Imerio Capone et al. Frontiers in Immunology
- Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial.
- (2018) Julien Mazieres et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 Women
- (2018) Rong Wang et al. Frontiers in Oncology
- Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics
- (2017) Maria A. Smolle et al. FEBS Journal
- Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines
- (2017) Lingyun Yang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Repurposing Antiestrogens for Tumor Immunotherapy
- (2017) Thomas Welte et al. Cancer Discovery
- Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer
- (2017) Jill M. Siegfried et al. Oncotarget
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer
- (2016) D. H. Hamilton et al. CLINICAL CANCER RESEARCH
- Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer
- (2016) Xiang-Qi Chen et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
- (2016) Kaja Skjefstad et al. STEROIDS
- Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
- (2016) Nikolaos Svoronos et al. Cancer Discovery
- Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
- (2016) Rossana Berardi et al. Oncotarget
- Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma
- (2016) Dakai Xiao et al. Oncotarget
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Estrogen receptors regulate innate immune cells and signaling pathways
- (2015) Susan Kovats CELLULAR IMMUNOLOGY
- CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
- (2015) S. Svensson et al. CLINICAL CANCER RESEARCH
- Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
- (2015) Y Yin et al. Clinics
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of estrogen receptors mRNA expression in non-small cell lung cancer: A systematic review and meta-analysis
- (2015) Wentao Li et al. STEROIDS
- Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration
- (2015) Kyuichi Kadota et al. Oncotarget
- Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis
- (2015) Xiao-Bin Gu et al. Scientific Reports
- Estrogen Receptor Beta and CXCR4/CXCL12 Expression: Differences by Sex and Hormonal Status in Lung Adenocarcinoma
- (2014) Vianey Rodriguez-Lara et al. ARCHIVES OF MEDICAL RESEARCH
- Estrogen adversely affects the prognosis of patients with lung adenocarcinoma
- (2014) Li-Han Hsu et al. CANCER SCIENCE
- Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer
- (2014) Kent Russell et al. Clinical Lung Cancer
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Clinicopathological and Demographical Characteristics of Non-Small Cell Lung Cancer Patients with ALK Rearrangements: A Systematic Review and Meta-Analysis
- (2014) Liang Fan et al. PLoS One
- Clinicopathologic Features of Patients with Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Gene: A Meta-Analysis
- (2014) Ying Wang et al. PLoS One
- Estrogen Receptor 1 Gene Expression and Its Combination with Estrogen Receptor 2 or Aromatase Expression Predicts Survival in Non-Small Cell Lung Cancer
- (2014) Unai Aresti et al. PLoS One
- Estrogen receptors (ERαversus ERβ): friends or foes in human biology?
- (2013) Sonia Lobo Planey et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked
- (2013) Julien Mazières et al. Journal of Thoracic Oncology
- Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer
- (2013) Edward B. Garon et al. Journal of Thoracic Oncology
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Estrogenic Steroid Hormones in Lung Cancer
- (2013) Jill M. Siegfried et al. SEMINARS IN ONCOLOGY
- Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada
- (2013) S. A. Lother et al. Hormones & Cancer
- Stromal Estrogen Receptor- Promotes Tumor Growth by Normalizing an Increased Angiogenesis
- (2012) C. Pequeux et al. CANCER RESEARCH
- The development of endocrine therapy for women with breast cancer
- (2012) Richard Sainsbury CANCER TREATMENT REVIEWS
- Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens
- (2012) Laura P. Stabile et al. CARCINOGENESIS
- Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
- (2012) Esdy N. Rozali et al. Clinical & Developmental Immunology
- Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
- (2012) S. Dogan et al. CLINICAL CANCER RESEARCH
- Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer
- (2012) Jill M. Siegfried et al. Journal of Thoracic Oncology
- Differential Role of Estrogen Receptor Beta in Early Versus Metastatic Non-small Cell Lung Cancer
- (2012) Sri Navaratnam et al. Hormones & Cancer
- Female Gender Is an Independent Prognostic Factor in Non-small-cell Lung Cancer: A Meta-analysis
- (2011) Haruhiko Nakamura et al. Annals of Thoracic and Cardiovascular Surgery
- Estrogen receptors, antiestrogens, and non-small cell lung cancer
- (2011) T. A. Bogush et al. BIOCHEMISTRY-MOSCOW
- Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer
- (2011) Marius Ilie et al. CANCER
- Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
- (2011) Christine Bouchardy et al. CANCER
- Sex Disparities in Cancer Mortality and Survival
- (2011) M. B. Cook et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer
- (2011) Vei Mah et al. LUNG CANCER
- Combined Analysis of Estrogen Receptor -1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome
- (2010) L. P. Stabile et al. CLINICAL CANCER RESEARCH
- Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study
- (2010) Christopher G. Slatore et al. JOURNAL OF CLINICAL ONCOLOGY
- B7-H1-Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
- (2010) P.-Y. Lin et al. JOURNAL OF IMMUNOLOGY
- Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial
- (2010) Rowan T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Analysis of Radiation Therapy Oncology Group Trials
- (2010) Farzan Siddiqui et al. Journal of Thoracic Oncology
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- The Xs and Y of immune responses to viral vaccines
- (2010) Sabra L Klein et al. LANCET INFECTIOUS DISEASES
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Targeting Aromatase and Estrogen Signaling in Human Non-Small Cell Lung Cancer
- (2009) Diana C. Márquez-Garbán et al. Annals of the New York Academy of Sciences
- Sex Disparities in Cancer Incidence by Period and Age
- (2009) M. B. Cook et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation
- (2009) M. G. Raso et al. CLINICAL CANCER RESEARCH
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells
- (2009) Pamela A. Hershberger et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Postmenopausal Hormone Therapy and Lung Cancer Risk in the Cancer Prevention Study II Nutrition Cohort
- (2008) C. Rodriguez et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Intratumoral Estrogens and Estrogen Receptors in Human Non-Small Cell Lung Carcinoma
- (2008) H. Niikawa et al. CLINICAL CANCER RESEARCH
- Association Between Estrogen Receptor-β Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung
- (2008) Naohiro Nose et al. JOURNAL OF CLINICAL ONCOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
- (2008) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer
- (2008) Anne M. Traynor et al. LUNG CANCER
- Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies
- (2008) Michael J Thun et al. PLOS MEDICINE
- Oestrogen receptor β over expression in males with non-small cell lung cancer is associated with better survival
- (2007) Birgit Guldhammer Skov et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started